Bu B[Author] - Search Results

Year	Number of Results
1986	1
1989	1
1990	2
1991	1
1999	2
2001	1
2002	2
2003	1
2004	2
2006	5
2007	1
2008	4
2009	5
2010	4
2011	2
2012	4
2013	8
2014	12
2015	12
2016	4
2017	11
2018	11
2019	15
2020	13
2021	18
2022	24
2023	17
2024	9

1

Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.

Ma X, Bu BT. Ma X, et al. Among authors: bu bt. Front Immunol. 2022 Oct 13;13:1019972. doi: 10.3389/fimmu.2022.1019972. eCollection 2022. Front Immunol. 2022. PMID: 36311711 Free PMC article. Review.

2

Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.

Qin C, Tian DS, Zhou LQ, Shang K, Huang L, Dong MH, You YF, Xiao J, Xiong Y, Wang W, Pang H, Guo JJ, Cai SB, Wang D, Li CR, Zhang M, Bu BT, Wang W. Qin C, et al. Among authors: bu bt. Signal Transduct Target Ther. 2023 Jan 4;8(1):5. doi: 10.1038/s41392-022-01278-3. Signal Transduct Target Ther. 2023. PMID: 36596762 Free PMC article. Clinical Trial.

3

Astrocyte-Derived Exosomes Contribute to Pathologies of Neuromyelitis Optica Spectrum Disorder in Rodent Model.

Xie Y, Chen B, Wang Q, Chen X, Lai W, Xu Y, Deng S, Yu Z, Xie M, Bu B, Mou D, Yi C, Ding F, Wang W. Xie Y, et al. Among authors: bu b. Ann Neurol. 2023 Jul;94(1):163-181. doi: 10.1002/ana.26650. Epub 2023 Apr 11. Ann Neurol. 2023. PMID: 36966488

4

B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.

Tian DS, Qin C, Dong MH, Heming M, Zhou LQ, Wang W, Cai SB, You YF, Shang K, Xiao J, Wang D, Li CR, Zhang M, Bu BT, Meyer Zu Hörste G, Wang W. Tian DS, et al. Among authors: bu bt. EMBO Mol Med. 2024 Apr;16(4):966-987. doi: 10.1038/s44321-024-00043-z. Epub 2024 Feb 26. EMBO Mol Med. 2024. PMID: 38409527 Free PMC article.

5

Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis.

Bi Z, Zhan J, Zhang Q, Gao H, Yang M, Ge H, Gui M, Lin J, Bu B. Bi Z, et al. Among authors: bu b. Front Immunol. 2023 May 17;14:1177249. doi: 10.3389/fimmu.2023.1177249. eCollection 2023. Front Immunol. 2023. PMID: 37266422 Free PMC article.

6

Batoclimab vs Placebo for Generalized Myasthenia Gravis: A Randomized Clinical Trial.

Yan C, Yue Y, Guan Y, Bu B, Ke Q, Duan R, Deng H, Xue Q, Jiang H, Xiao F, Yang H, Chang T, Zou Z, Li H, Tan S, Xiao H, Zhou H, Zhang H, Meng Q, Li W, Li W, Guo J, Zhang Y, Li Z, Tu J, Shi J, Li W, Lee M, Chen Y, Tao X, Zhao S, Li P, Zhao C; Batoclimab Study Team. Yan C, et al. Among authors: bu b. JAMA Neurol. 2024 Mar 4;81(4):336-45. doi: 10.1001/jamaneurol.2024.0044. Online ahead of print. JAMA Neurol. 2024. PMID: 38436998

7

Therapeutic potential of natural killer cells in neuroimmunological diseases.

Zhang Q, Lin J, Yang M, Li Z, Zhang M, Bu B. Zhang Q, et al. Among authors: bu b. Biomed Pharmacother. 2024 Apr;173:116371. doi: 10.1016/j.biopha.2024.116371. Epub 2024 Mar 2. Biomed Pharmacother. 2024. PMID: 38430631 Free article. Review.

8

Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy.

Qin C, Dong MH, Zhou LQ, Wang W, Cai SB, You YF, Shang K, Xiao J, Wang D, Li CR, Zhang M, Bu BT, Tian DS, Wang W. Qin C, et al. Among authors: bu bt. Proc Natl Acad Sci U S A. 2024 Feb 6;121(6):e2315990121. doi: 10.1073/pnas.2315990121. Epub 2024 Jan 30. Proc Natl Acad Sci U S A. 2024. PMID: 38289960 Free PMC article.

9

Viral oncogenes, viruses, and cancer: a third-generation sequencing perspective on viral integration into the human genome.

Ye R, Wang A, Bu B, Luo P, Deng W, Zhang X, Yin S. Ye R, et al. Among authors: bu b. Front Oncol. 2023 Dec 21;13:1333812. doi: 10.3389/fonc.2023.1333812. eCollection 2023. Front Oncol. 2023. PMID: 38188304 Free PMC article. Review.

10

TWEAK and Fn14 are overexpressed in immune-mediated necrotizing myopathy: implications for muscle damage and repair.

Yang M, Ge H, Ji S, Li Y, Xu L, Bi Z, Bu B. Yang M, et al. Among authors: bu b. Rheumatology (Oxford). 2023 Nov 2;62(11):3732-3741. doi: 10.1093/rheumatology/kead108. Rheumatology (Oxford). 2023. PMID: 36916753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

174 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Results by year